Pharma & Healthcare
Global Human Immunodeficiency Virus Type-1 Market Research Report 2026
- Mar 17, 26
- ID: 741101
- Pages: 107
- Figures: 101
- Views: 2
This report delivers a comprehensive overview of the global Human Immunodeficiency Virus Type-1 market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Immunodeficiency Virus Type-1. The Human Immunodeficiency Virus Type-1 market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Immunodeficiency Virus Type-1 market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Immunodeficiency Virus Type-1 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Bristol Myers Squibb
Merck & Co. Inc.
GSK
Pfizer
Viatris
Sanofi
AstraZeneca
Novartis
Bayer
Segment by Type
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
Protease Inhibitors (PIs)
Integrase Inhibitor
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Human Immunodeficiency Virus Type-1 companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Human Immunodeficiency Virus Type-1 market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Immunodeficiency Virus Type-1 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Bristol Myers Squibb
Merck & Co. Inc.
GSK
Pfizer
Viatris
Sanofi
AstraZeneca
Novartis
Bayer
Segment by Type
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
Protease Inhibitors (PIs)
Integrase Inhibitor
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Human Immunodeficiency Virus Type-1 companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.3 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
1.2.4 Protease Inhibitors (PIs)
1.2.5 Integrase Inhibitor
1.2.6 Others
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus Type-1 Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus Type-1 Market Perspective (2021–2032)
2.2 Global Human Immunodeficiency Virus Type-1 Growth Trends by Region
2.2.1 Global Human Immunodeficiency Virus Type-1 Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Human Immunodeficiency Virus Type-1 Historic Market Size by Region (2021–2026)
2.2.3 Human Immunodeficiency Virus Type-1 Forecasted Market Size by Region (2027–2032)
2.3 Human Immunodeficiency Virus Type-1 Market Dynamics
2.3.1 Human Immunodeficiency Virus Type-1 Industry Trends
2.3.2 Human Immunodeficiency Virus Type-1 Market Drivers
2.3.3 Human Immunodeficiency Virus Type-1 Market Challenges
2.3.4 Human Immunodeficiency Virus Type-1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus Type-1 Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus Type-1 Players by Revenue (2021–2026)
3.1.2 Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Players (2021–2026)
3.2 Global Top Human Immunodeficiency Virus Type-1 Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Human Immunodeficiency Virus Type-1 Revenue
3.4 Global Human Immunodeficiency Virus Type-1 Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus Type-1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus Type-1 Revenue in 2025
3.5 Global Key Players of Human Immunodeficiency Virus Type-1 Head Offices and Areas Served
3.6 Global Key Players of Human Immunodeficiency Virus Type-1, Products and Applications
3.7 Global Key Players of Human Immunodeficiency Virus Type-1, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Human Immunodeficiency Virus Type-1 Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus Type-1 Historic Market Size by Type (2021–2026)
4.2 Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Type (2027–2032)
5 Human Immunodeficiency Virus Type-1 Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus Type-1 Historic Market Size by Application (2021–2026)
5.2 Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
6.2 North America Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)
6.4 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
7.2 Europe Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)
7.4 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
8.2 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2021–2026)
8.4 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
9.2 Latin America Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)
9.4 Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
10.2 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)
10.4 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Human Immunodeficiency Virus Type-1 Introduction
11.1.4 Roche Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Introduction
11.2.4 Bristol Myers Squibb Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Merck & Co. Inc.
11.3.1 Merck & Co. Inc. Company Details
11.3.2 Merck & Co. Inc. Business Overview
11.3.3 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Introduction
11.3.4 Merck & Co. Inc. Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.3.5 Merck & Co. Inc. Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Human Immunodeficiency Virus Type-1 Introduction
11.4.4 GSK Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.4.5 GSK Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Human Immunodeficiency Virus Type-1 Introduction
11.5.4 Pfizer Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.5.5 Pfizer Recent Development
11.6 Viatris
11.6.1 Viatris Company Details
11.6.2 Viatris Business Overview
11.6.3 Viatris Human Immunodeficiency Virus Type-1 Introduction
11.6.4 Viatris Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.6.5 Viatris Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Human Immunodeficiency Virus Type-1 Introduction
11.7.4 Sanofi Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.7.5 Sanofi Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Human Immunodeficiency Virus Type-1 Introduction
11.8.4 AstraZeneca Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Human Immunodeficiency Virus Type-1 Introduction
11.9.4 Novartis Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.9.5 Novartis Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Human Immunodeficiency Virus Type-1 Introduction
11.10.4 Bayer Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.10.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.3 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
1.2.4 Protease Inhibitors (PIs)
1.2.5 Integrase Inhibitor
1.2.6 Others
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus Type-1 Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus Type-1 Market Perspective (2021–2032)
2.2 Global Human Immunodeficiency Virus Type-1 Growth Trends by Region
2.2.1 Global Human Immunodeficiency Virus Type-1 Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Human Immunodeficiency Virus Type-1 Historic Market Size by Region (2021–2026)
2.2.3 Human Immunodeficiency Virus Type-1 Forecasted Market Size by Region (2027–2032)
2.3 Human Immunodeficiency Virus Type-1 Market Dynamics
2.3.1 Human Immunodeficiency Virus Type-1 Industry Trends
2.3.2 Human Immunodeficiency Virus Type-1 Market Drivers
2.3.3 Human Immunodeficiency Virus Type-1 Market Challenges
2.3.4 Human Immunodeficiency Virus Type-1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus Type-1 Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus Type-1 Players by Revenue (2021–2026)
3.1.2 Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Players (2021–2026)
3.2 Global Top Human Immunodeficiency Virus Type-1 Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Human Immunodeficiency Virus Type-1 Revenue
3.4 Global Human Immunodeficiency Virus Type-1 Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus Type-1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus Type-1 Revenue in 2025
3.5 Global Key Players of Human Immunodeficiency Virus Type-1 Head Offices and Areas Served
3.6 Global Key Players of Human Immunodeficiency Virus Type-1, Products and Applications
3.7 Global Key Players of Human Immunodeficiency Virus Type-1, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Human Immunodeficiency Virus Type-1 Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus Type-1 Historic Market Size by Type (2021–2026)
4.2 Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Type (2027–2032)
5 Human Immunodeficiency Virus Type-1 Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus Type-1 Historic Market Size by Application (2021–2026)
5.2 Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
6.2 North America Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)
6.4 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
7.2 Europe Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)
7.4 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
8.2 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2021–2026)
8.4 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
9.2 Latin America Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)
9.4 Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size (2021–2032)
10.2 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)
10.4 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Human Immunodeficiency Virus Type-1 Introduction
11.1.4 Roche Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Introduction
11.2.4 Bristol Myers Squibb Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Merck & Co. Inc.
11.3.1 Merck & Co. Inc. Company Details
11.3.2 Merck & Co. Inc. Business Overview
11.3.3 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Introduction
11.3.4 Merck & Co. Inc. Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.3.5 Merck & Co. Inc. Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Human Immunodeficiency Virus Type-1 Introduction
11.4.4 GSK Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.4.5 GSK Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Human Immunodeficiency Virus Type-1 Introduction
11.5.4 Pfizer Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.5.5 Pfizer Recent Development
11.6 Viatris
11.6.1 Viatris Company Details
11.6.2 Viatris Business Overview
11.6.3 Viatris Human Immunodeficiency Virus Type-1 Introduction
11.6.4 Viatris Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.6.5 Viatris Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Human Immunodeficiency Virus Type-1 Introduction
11.7.4 Sanofi Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.7.5 Sanofi Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Human Immunodeficiency Virus Type-1 Introduction
11.8.4 AstraZeneca Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Human Immunodeficiency Virus Type-1 Introduction
11.9.4 Novartis Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.9.5 Novartis Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Human Immunodeficiency Virus Type-1 Introduction
11.10.4 Bayer Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)
11.10.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 3. Key Players of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
Table 4. Key Players of Protease Inhibitors (PIs)
Table 5. Key Players of Integrase Inhibitor
Table 6. Key Players of Others
Table 7. Global Human Immunodeficiency Virus Type-1 Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2021–2026
Table 10. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2021–2026)
Table 11. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2027–2032)
Table 13. Human Immunodeficiency Virus Type-1 Market Trends
Table 14. Human Immunodeficiency Virus Type-1 Market Drivers
Table 15. Human Immunodeficiency Virus Type-1 Market Challenges
Table 16. Human Immunodeficiency Virus Type-1 Market Restraints
Table 17. Global Human Immunodeficiency Virus Type-1 Revenue by Players (US$ Million), 2021–2026
Table 18. Global Human Immunodeficiency Virus Type-1 Market Share by Players (2021–2026)
Table 19. Global Top Human Immunodeficiency Virus Type-1 Players by Tier (Tier 1, Tier 2, and Tier 3), based on Human Immunodeficiency Virus Type-1 Revenue, 2025
Table 20. Ranking of Global Top Human Immunodeficiency Virus Type-1 Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Human Immunodeficiency Virus Type-1 Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Human Immunodeficiency Virus Type-1, Headquarters and Area Served
Table 23. Global Key Players of Human Immunodeficiency Virus Type-1, Products and Applications
Table 24. Global Key Players of Human Immunodeficiency Virus Type-1, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Human Immunodeficiency Virus Type-1 Market Size by Type (US$ Million), 2021–2026
Table 27. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2021–2026)
Table 28. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2027–2032)
Table 30. Global Human Immunodeficiency Virus Type-1 Market Size by Application (US$ Million), 2021–2026
Table 31. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2021–2026)
Table 32. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2027–2032)
Table 34. North America Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026
Table 36. North America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032
Table 49. Roche Company Details
Table 50. Roche Business Overview
Table 51. Roche Human Immunodeficiency Virus Type-1 Product
Table 52. Roche Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 53. Roche Recent Development
Table 54. Bristol Myers Squibb Company Details
Table 55. Bristol Myers Squibb Business Overview
Table 56. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product
Table 57. Bristol Myers Squibb Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 58. Bristol Myers Squibb Recent Development
Table 59. Merck & Co. Inc. Company Details
Table 60. Merck & Co. Inc. Business Overview
Table 61. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product
Table 62. Merck & Co. Inc. Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 63. Merck & Co. Inc. Recent Development
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Human Immunodeficiency Virus Type-1 Product
Table 67. GSK Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 68. GSK Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Human Immunodeficiency Virus Type-1 Product
Table 72. Pfizer Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 73. Pfizer Recent Development
Table 74. Viatris Company Details
Table 75. Viatris Business Overview
Table 76. Viatris Human Immunodeficiency Virus Type-1 Product
Table 77. Viatris Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 78. Viatris Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Human Immunodeficiency Virus Type-1 Product
Table 82. Sanofi Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 83. Sanofi Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Human Immunodeficiency Virus Type-1 Product
Table 87. AstraZeneca Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 88. AstraZeneca Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Human Immunodeficiency Virus Type-1 Product
Table 92. Novartis Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 93. Novartis Recent Development
Table 94. Bayer Company Details
Table 95. Bayer Business Overview
Table 96. Bayer Human Immunodeficiency Virus Type-1 Product
Table 97. Bayer Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 98. Bayer Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Human Immunodeficiency Virus Type-1 Picture
Figure 2. Global Human Immunodeficiency Virus Type-1 Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Human Immunodeficiency Virus Type-1 Market Share by Type: 2025 vs 2032
Figure 4. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 5. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 6. Protease Inhibitors (PIs) Features
Figure 7. Integrase Inhibitor Features
Figure 8. Others Features
Figure 9. Global Human Immunodeficiency Virus Type-1 Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Human Immunodeficiency Virus Type-1 Market Share by Application: 2025 vs 2032
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Human Immunodeficiency Virus Type-1 Report Years Considered
Figure 14. Global Human Immunodeficiency Virus Type-1 Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Human Immunodeficiency Virus Type-1 Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Human Immunodeficiency Virus Type-1 Market Share by Region: 2025 vs 2032
Figure 17. Global Human Immunodeficiency Virus Type-1 Market Share by Players in 2025
Figure 18. Global Human Immunodeficiency Virus Type-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus Type-1 Revenue in 2025
Figure 20. North America Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)
Figure 22. United States Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)
Figure 26. Germany Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Share by Region (2021–2032)
Figure 34. China Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)
Figure 42. Mexico Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)
Figure 46. Israel Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Roche Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 50. Bristol Myers Squibb Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 51. Merck & Co. Inc. Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 52. GSK Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 53. Pfizer Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 54. Viatris Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 55. Sanofi Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 56. AstraZeneca Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 57. Novartis Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 58. Bayer Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 3. Key Players of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
Table 4. Key Players of Protease Inhibitors (PIs)
Table 5. Key Players of Integrase Inhibitor
Table 6. Key Players of Others
Table 7. Global Human Immunodeficiency Virus Type-1 Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2021–2026
Table 10. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2021–2026)
Table 11. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2027–2032)
Table 13. Human Immunodeficiency Virus Type-1 Market Trends
Table 14. Human Immunodeficiency Virus Type-1 Market Drivers
Table 15. Human Immunodeficiency Virus Type-1 Market Challenges
Table 16. Human Immunodeficiency Virus Type-1 Market Restraints
Table 17. Global Human Immunodeficiency Virus Type-1 Revenue by Players (US$ Million), 2021–2026
Table 18. Global Human Immunodeficiency Virus Type-1 Market Share by Players (2021–2026)
Table 19. Global Top Human Immunodeficiency Virus Type-1 Players by Tier (Tier 1, Tier 2, and Tier 3), based on Human Immunodeficiency Virus Type-1 Revenue, 2025
Table 20. Ranking of Global Top Human Immunodeficiency Virus Type-1 Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Human Immunodeficiency Virus Type-1 Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Human Immunodeficiency Virus Type-1, Headquarters and Area Served
Table 23. Global Key Players of Human Immunodeficiency Virus Type-1, Products and Applications
Table 24. Global Key Players of Human Immunodeficiency Virus Type-1, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Human Immunodeficiency Virus Type-1 Market Size by Type (US$ Million), 2021–2026
Table 27. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2021–2026)
Table 28. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2027–2032)
Table 30. Global Human Immunodeficiency Virus Type-1 Market Size by Application (US$ Million), 2021–2026
Table 31. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2021–2026)
Table 32. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2027–2032)
Table 34. North America Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026
Table 36. North America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032
Table 49. Roche Company Details
Table 50. Roche Business Overview
Table 51. Roche Human Immunodeficiency Virus Type-1 Product
Table 52. Roche Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 53. Roche Recent Development
Table 54. Bristol Myers Squibb Company Details
Table 55. Bristol Myers Squibb Business Overview
Table 56. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product
Table 57. Bristol Myers Squibb Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 58. Bristol Myers Squibb Recent Development
Table 59. Merck & Co. Inc. Company Details
Table 60. Merck & Co. Inc. Business Overview
Table 61. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product
Table 62. Merck & Co. Inc. Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 63. Merck & Co. Inc. Recent Development
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Human Immunodeficiency Virus Type-1 Product
Table 67. GSK Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 68. GSK Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Human Immunodeficiency Virus Type-1 Product
Table 72. Pfizer Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 73. Pfizer Recent Development
Table 74. Viatris Company Details
Table 75. Viatris Business Overview
Table 76. Viatris Human Immunodeficiency Virus Type-1 Product
Table 77. Viatris Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 78. Viatris Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Human Immunodeficiency Virus Type-1 Product
Table 82. Sanofi Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 83. Sanofi Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Human Immunodeficiency Virus Type-1 Product
Table 87. AstraZeneca Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 88. AstraZeneca Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Human Immunodeficiency Virus Type-1 Product
Table 92. Novartis Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 93. Novartis Recent Development
Table 94. Bayer Company Details
Table 95. Bayer Business Overview
Table 96. Bayer Human Immunodeficiency Virus Type-1 Product
Table 97. Bayer Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026
Table 98. Bayer Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Human Immunodeficiency Virus Type-1 Picture
Figure 2. Global Human Immunodeficiency Virus Type-1 Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Human Immunodeficiency Virus Type-1 Market Share by Type: 2025 vs 2032
Figure 4. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 5. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 6. Protease Inhibitors (PIs) Features
Figure 7. Integrase Inhibitor Features
Figure 8. Others Features
Figure 9. Global Human Immunodeficiency Virus Type-1 Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Human Immunodeficiency Virus Type-1 Market Share by Application: 2025 vs 2032
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Human Immunodeficiency Virus Type-1 Report Years Considered
Figure 14. Global Human Immunodeficiency Virus Type-1 Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Human Immunodeficiency Virus Type-1 Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Human Immunodeficiency Virus Type-1 Market Share by Region: 2025 vs 2032
Figure 17. Global Human Immunodeficiency Virus Type-1 Market Share by Players in 2025
Figure 18. Global Human Immunodeficiency Virus Type-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus Type-1 Revenue in 2025
Figure 20. North America Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)
Figure 22. United States Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)
Figure 26. Germany Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Share by Region (2021–2032)
Figure 34. China Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)
Figure 42. Mexico Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)
Figure 46. Israel Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Roche Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 50. Bristol Myers Squibb Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 51. Merck & Co. Inc. Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 52. GSK Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 53. Pfizer Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 54. Viatris Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 55. Sanofi Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 56. AstraZeneca Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 57. Novartis Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 58. Bayer Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232